Inicio › Hemofilia › California
Ensayos clínicos de Hemofilia en California
14 estudios sobre Hemofilia buscan participantes en California.
Ciudades en California
Texto oficial del estudio (inglés)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- The Regents of the University of California||UC Davis Health, Rancho Cordova
- UC Davis Health, Sacramento
- UC Davis Ambulatory Care Clinic, Sacramento
- y 3 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 2 oct 2026 · NCT05568719A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
- Children's Hospital Los Angeles- Site Number : 8400005, Los Angeles
ReclutandoFase 4
Edades de 12 en adelante · Hombres · Actualizado el 23 sept 2026 · NCT06145373A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
- UC Davis Cancer Center, Sacramento
ReclutandoFase 1/2
Edades de 2 a 59 · Hombres · Actualizado el 11 sept 2026 · NCT05987449A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
- Center for Inherited Blood Disorders, Orange
- University of California San Francisco, San Francisco
- Kaiser Permanente, Vallejo
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 11 sept 2026 · NCT07226206A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Center for Inherited Blood Disorders, Orange
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07416604Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Lucile Packard Children's Hospital, Palo Alto
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 0 a 20 · Todos los sexos · Actualizado el 21 ago 2026 · NCT04278404ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Orthopaedic Institute for Children HTC, Los Angeles
- Childrens Hospital Los Angeles, Los Angeles
- UCSF Benioff Children's Hospital Oakland, Oakland
- y 5 más
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 17 ago 2026 · NCT04398628A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
- The Luskin Orthopaedic Institute for Children- Site Number : 8400013, Los Angeles
- The Center for Inherited Blood Disorders- Site Number : 8400009, Orange
ReclutandoFase 3
Edades de 1 a 11 · Hombres · Actualizado el 17 ago 2026 · NCT07285460Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Stanford University, Palo Alto
- Rady Children's Hospital, San Diego
ReclutandoEstudio observacional
Edades de 6 a 19 · Todos los sexos · Actualizado el 2 jul 2026 · NCT05022459A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- Children's Hospital Los Angeles, Los Angeles
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 60 · Todos los sexos · Actualizado el 2 jul 2026 · NCT06349473A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
- Orthopaedic Institute for Children/Orthopaedic Hemophilia Treatment Center, Los Angeles
ReclutandoFase 1
Edades de 12 a 74 · Hombres · Actualizado el 3 jun 2026 · NCT06703606Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD), Orange
- Stanford University: Stanford Children's Health, Redwood City
ReclutandoFase 1
Edades de 0 a 90 · Todos los sexos · Actualizado el 3 abr 2026 · NCT05500807SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Orthopaedic Institute for Children, Los Angeles
- University of California at Davis UC Davis Hemostasis and Thrombosis Center, Sacramento
ReclutandoFase 4
Edades de 12 a 100 · Todos los sexos · Actualizado el 12 ene 2026 · NCT04647227Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
- Orthopedic Institute for Children- Site Number : 8400009, Los Angeles
ReclutandoFase 4
Edades de 12 en adelante · Todos los sexos · Actualizado el 18 nov 2025 · NCT06941870De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.